This variability depends on baseline metabolic rate, previous weight cycling history, and individual GLP-1 receptor sensitivity
Both medications require a prescription from a licensed medical doctor practicing within the USA
et al., 2023), gut microbiota dysbiosis and elevated peripheral and central inflammation levels are often detected, indicating that gut microbiota may contribute to disease development through immunemediated neuroinflammatory pathways (Lobionda et al., 2019)
In the realm of weight management and metabolic health, semaglutide has emerged as a promising medication, attracting significant attention from both medical professionals and patients
Chouhan A, Shah SK, Tyagi CK, Budholiya P, Wazid A, Khan F